EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IDAP: an integrated literature- and knowledge-graph-driven evidence prioritization pipeline for precision oncology

Yebin Ryu, Ha-Eun Jeong, Joon-Yong An iD

Bioinformatics · 03.05.2026 · 42 (5)

DOI: 10.1093/bioinformatics/btag300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 09.05.2026. Verfasst von Yebin Ryu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Biomedical and Life Science, Korea University, Seoul, 02841, Republic of Korea. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms, Computational Biology, Medical Oncology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health & Welfare, Republic of Korea, National Research Foundation of Korea (NRF), Korea government (Ministry of Science and ICT and Ministry of Education).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation Advances in tumor sequencing enable routine detection of dozens to hundreds of somatic alterations per patient, yet only a minority can be linked to established therapeutic evidence. Curated resources such as OncoKB provide high-quality variant-drug annotations but remain limited in coverage, particularly for rare or low-frequency variants. This coverage gap motivates computational frameworks that can integrate curated, literature-derived, graph-based, and clinical-trial evidence to prioritize therapeutic hypotheses for expert review. Results We developed the Integrated Drug Annotation Pipeline (IDAP), a modular framework that combines four complementary evidence streams: curated variant-drug associations from OncoKB, literature-derived gene-drug mention counts from PubMed abstracts, graph-based drug prioritization using a TxGNN-derived biomedical knowledge graph, and cancer-specific clinical-trial evidence from ClinicalTrials.gov. Given a cancer type and a MAF file, IDAP generates patient-level reports summarizing detected variants, ranked therapeutic hypotheses, supporting evidence layers, and relevant clinical trials. Evaluated across five cancer types (n = 50 samples), IDAP expanded evidence-linked therapeutic hypotheses beyond curated databases alone. Among patients without OncoKB recommendations (26/50), IDAP identified a median of 87 candidate drugs (range: 2–473). To reduce cross-source scale imbalance, the final ranking used within-sample percentile normalization with fixed bonuses for curated evidence, multi-source support, and trial linkage. Under this revised ranking, 24/50 top-ranked candidates were supported by at least two evidence sources and 44/50 had associated ClinicalTrials metadata. In an exploratory external CIViC comparison, IDAP recovered at least one matched CIViC-supported therapy in 28/41 eligible samples, with 13/41 appearing within the top 10 candidates. These outputs are intended to support evidence triage and translational interpretation rather than direct treatment recommendation. Availability and implementation IDAP is freely available at https://github.com/joonan-lab/IDAP-pipeline, with full documentation at https://joonan-lab.github.io/IDAP-pipeline. An archived snapshot of the code used in this study is deposited on Zenodo (DOI: https://doi.org/10.5281/zenodo.19301367)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineNeoplasmsComputational BiologyMedical OncologySoftwareHumansAntineoplastic AgentsBiocuration

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Integrated Biomedical and Life Science, Korea University, Seoul, 02841, Republic of Korea.
  • L-HOPE Program for Community-Based Total Learning Health Systems, Korea University, Seoul, 02841, Republic of Korea.
  • National Research Laboratory for Convergence Degradation Biology, Korea University, Seoul, 02841, Republic of Korea.
  • School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, 02841, Republic of Korea.

ORCID-Profile: Joon-Yong An

Förderung

  • Ministry of Health & Welfare, Republic of Korea
  • National Research Foundation of Korea (NRF)
  • Korea government (Ministry of Science and ICT and Ministry of Education)
  • Korea University BK21 FOUR Academic Writing
  • Korea University

Zitieren

APA

Ryu, Y., Jeong, H. E., & An, J. Y. (2026). IDAP: an integrated literature- and knowledge-graph-driven evidence prioritization pipeline for precision oncology. Bioinformatics, 42(5). https://doi.org/10.1093/bioinformatics/btag300

Vancouver

Ryu Y, Jeong HE, An JY. IDAP: an integrated literature- and knowledge-graph-driven evidence prioritization pipeline for precision oncology. Bioinformatics. 2026;42(5). doi:10.1093/bioinformatics/btag300

BibTeX
@article{Ryu2026,
  author = {Ryu, Yebin and Jeong, Ha-Eun and An, Joon-Yong},
  title = {IDAP: an integrated literature- and knowledge-graph-driven evidence prioritization pipeline for precision oncology},
  journal = {Bioinformatics},
  year = {2026},
  volume = {42},
  number = {5},
  doi = {10.1093/bioinformatics/btag300}
}
Kostenlos starten →